Mylan N.V. (MYL +5.7%) announces that
its production of malaria med hydroxychloroquine sulfate at its
Morgantown, WV site has advanced ahead of schedule and has enabled the
supply of additional product earlier than expected for COVID-19
patients.
It is donating 10M doses to the U.S. Department of
Health and Human Services for possible use in clinical studies or under
emergency use authorization. It is also donating product to the World
Health Organization (WHO).
Shipments to wholesalers are underway.
https://seekingalpha.com/news/3559464-mylan-to-donate-10m-doses-of-malaria-drug-production-ramps-up
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.